Showing 1 - 4 results of 4 for search 'Quanju Zhao', query time: 0.02s Refine Results
  1. 1
    Mycobacterium tuberculosis Rv3402c enhances mycobacterial survival within macrophages and modulates the host pro-inflammatory cytokines production via NF-kappa B/ERK/p38 signaling.

    Mycobacterium tuberculosis Rv3402c enhances mycobacterial survival within macrophages and modulates the host pro-inflammatory cytokines production via NF-kappa B/ERK/p38 signaling. by Wu Li, Quanju Zhao, Wanyan Deng, Tian Chen, Minqiang Liu, Jianping Xie

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Mycobacterium Tuberculosis PPE Family Protein Rv1808 Manipulates Cytokines Profile via Co-Activation of MAPK and NF-κB Signaling Pathways

    Mycobacterium Tuberculosis PPE Family Protein Rv1808 Manipulates Cytokines Profile via Co-Activation of MAPK and NF-κB Signaling Pathways by Wanyan Deng, Wu Li, Jie Zeng, Quanju Zhao, Chunmei Li, Yuzhong Zhao, Jianping Xie

    Published 2014-01-01
    Get full text
    Article
  3. 3
    1355 DM919, an IND-ready MICA/B-specific antibody, reinforces NKG2D-MICA/B axis and promotes anti-tumor activities

    1355 DM919, an IND-ready MICA/B-specific antibody, reinforces NKG2D-MICA/B axis and promotes anti-tumor activities by Yi Xu, Dong Zhang, Nan Bing, Hong Chang, Sheng Yin, Guangan Hu, Quanju Zhao, Xiaochun Chen, Xiaodong Jiang

    Published 2023-11-01
    Article
  4. 4
    1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models

    1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models by Yi Xu, Dong Zhang, Nan Bing, Hong Chang, Sheng Yin, Guangan Hu, Quanju Zhao, Xiaochun Chen, Xiaodong Jiang

    Published 2023-11-01
    Article

Search Tools: